These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 23731655

  • 1. Molecular cloning and biologically active production of IpaD N-terminal region.
    Hesaraki M, Saadati M, Honari H, Olad G, Heiat M, Malaei F, Ranjbar R.
    Biologicals; 2013 Jul; 41(4):269-74. PubMed ID: 23731655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR, Saadati M, Honari H, Ghorbani HM.
    Iran J Immunol; 2019 Sep; 16(3):212-224. PubMed ID: 31552830
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mapping the functional B-cell epitopes of Shigella invasion plasmid antigen D (IpaD).
    Li S, Zhang W.
    Appl Environ Microbiol; 2024 Aug 21; 90(8):e0098824. PubMed ID: 39082807
    [Abstract] [Full Text] [Related]

  • 6. Immunogenic Potency of a Chimeric Protein Comprising InvH and IpaD against Salmonella and Shigella spp.
    Emami Mahmoudabadi FS, Vakili A, Nazarian S, Amani J, Mousavi Gargari SL.
    Iran J Allergy Asthma Immunol; 2021 Aug 07; 20(4):484-493. PubMed ID: 34418902
    [Abstract] [Full Text] [Related]

  • 7. Multiplexed immunoassay to assess Shigella-specific antibody responses.
    Kaminski RW, Clarkson K, Kordis AA, Oaks EV.
    J Immunol Methods; 2013 Jul 31; 393(1-2):18-29. PubMed ID: 23583496
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV, Roberts F, Verma NK.
    FEMS Immunol Med Microbiol; 2006 Apr 31; 46(3):444-51. PubMed ID: 16553820
    [Abstract] [Full Text] [Related]

  • 10. Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies.
    Camacho AI, Souza-Rebouças J, Irache JM, Gamazo C.
    Methods; 2013 May 01; 60(3):264-8. PubMed ID: 23046911
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SipD and IpaD induce a cross-protection against Shigella and Salmonella infections.
    Jneid B, Rouaix A, Féraudet-Tarisse C, Simon S.
    PLoS Negl Trop Dis; 2020 May 01; 14(5):e0008326. PubMed ID: 32463817
    [Abstract] [Full Text] [Related]

  • 15. An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype.
    Mitobe J, Sinha R, Mitra S, Nag D, Saito N, Shimuta K, Koizumi N, Koley H.
    PLoS Negl Trop Dis; 2017 Jul 01; 11(7):e0005728. PubMed ID: 28727722
    [Abstract] [Full Text] [Related]

  • 16. Protective immunity by oral immunization with heat-killed Shigella strains in a guinea pig colitis model.
    Barman S, Koley H, Ramamurthy T, Chakrabarti MK, Shinoda S, Nair GB, Takeda Y.
    Microbiol Immunol; 2013 Nov 01; 57(11):762-71. PubMed ID: 24033533
    [Abstract] [Full Text] [Related]

  • 17. Protective immunization against Enterohemorrhagic Escherichia coli and Shigella dysenteriae Type 1 by chitosan nanoparticle loaded with recombinant chimeric antigens comprising EIT and STX1B-IpaD.
    Mosadegh S, Abtahi H, Amani J, Karizi SZ, Salmanian AH.
    Microb Pathog; 2023 Nov 01; 184():106344. PubMed ID: 37704060
    [Abstract] [Full Text] [Related]

  • 18. Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex.
    Turbyfill KR, Clarkson KA, Vortherms AR, Oaks EV, Kaminski RW.
    mSphere; 2018 Nov 01; 3(2):. PubMed ID: 29600284
    [Abstract] [Full Text] [Related]

  • 19. New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies.
    Shim DH, Suzuki T, Chang SY, Park SM, Sansonetti PJ, Sasakawa C, Kweon MN.
    J Immunol; 2007 Feb 15; 178(4):2476-82. PubMed ID: 17277155
    [Abstract] [Full Text] [Related]

  • 20. Live non-invasive Shigella dysenteriae 1 strain induces homologous protective immunity in a guinea pig colitis model.
    Barman S, Kumar R, Chowdhury G, Rani Saha D, Wajima T, Hamabata T, Ramamurthy T, Balakrish Nair G, Takeda Y, Koley H.
    Microbiol Immunol; 2011 Oct 15; 55(10):683-93. PubMed ID: 21806676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.